BlackRock Fund Advisors’s NEPHROGENEX INC COM NRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-15,848
Closed -$7K 4377
2016
Q1
$7K Sell
15,848
-1,306
-8% -$1.09K ﹤0.01% 4048
2015
Q4
$27K Buy
17,154
+545
+3% +$1.27K ﹤0.01% 3943
2015
Q3
$56K Buy
16,609
+7,285
+78% +$32K ﹤0.01% 3802
2015
Q2
$62K Buy
9,324
+1,130
+14% +$8.59K ﹤0.01% 3801
2015
Q1
$64K Buy
+8,194
New +$64.3K ﹤0.01% 3673

BlackRock Fund Advisors's NRX Position: Q2 2016 in Review

BlackRock Fund Advisors sold out of NEPHROGENEX INC COM (NRX) in Q2 2016, closing a stake of 15,848 shares — an estimated $7K sold.

BlackRock Fund Advisors first reported a position in NRX in Q1 2015 and held it in 5 quarters. The position peaked at $64K in Q1 2015. 1 fund tracked by Wall St. Rank holds NRX as of Q2 2016.

  • BlackRock Fund Advisors reported no remaining NEPHROGENEX INC COM position as of Q2 2016 after selling out during the quarter.
  • BlackRock Fund Advisors sold 15,848 NEPHROGENEX INC COM shares in Q2 2016, an estimated $7K.
  • BlackRock Fund Advisors first reported a position in NEPHROGENEX INC COM in Q1 2015 and held it in 5 quarters.
  • BlackRock Fund Advisors's NEPHROGENEX INC COM position peaked at $64K in Q1 2015.
  • 1 fund tracked by Wall St. Rank held NEPHROGENEX INC COM as of Q2 2016.

Based on BlackRock Fund Advisors's 13F filing for Q2 2016, filed 10 Aug 2016.